Investor / Analyst Presentation for the Quarter and Year ended 31st March 2026.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sharda Cropchem reported outstanding Q4 and FY26 results driven by volume growth and margin expansion. Q4 FY26 revenue grew 13% to Rs. 2,065 Cr with gross margins improving 750 basis points to 37.3%, while EBITDA surged 75% to Rs. 513 Cr and PAT jumped 57% to Rs. 319 Cr. Full year FY26 saw even stronger performance with 22% revenue growth to Rs. 5,268 Cr, EBITDA up 69% to Rs. 1,040 Cr and PAT more than doubling to Rs. 681 Cr. Volume growth was robust at 13.3% in agrochemicals and 15.3% in non-agrochemicals. The company expanded its registration library to 3,011 registrations and operates across 80+ countries with an asset-light model.
The sharp margin improvement (600-750 bps) reflects operating leverage and product mix benefits, with management guiding these elevated margin levels to sustain into FY27, signaling a structurally more profitable business.